InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	SIRTEX MEDICAL LIMITED (SRX)
Date of Listing:	24 August 2000
Date of Delisting:	24 September 2018

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 24 September 2018.

Legal Status: (updated monthly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

SIRTEX MEDICAL LIMITED(SRX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of SRX:

(5 out of 5)

COMPANY WEBSITE:

SRX website

SRX email

SRX investorRelations

SRX announcements

SRX annualreports

SRX directors

REGISTRY:

Level 12, 680 George Street Sydney NSW 2000

Tel : 61 1300 554 474
Fax : 02 9287 0303
RegistryWebsite RegistryEmail

Company details

Address: Level 33, 101 Miller Street, NORTH SYDNEY, NSW, AUSTRALIA, 2060
Tel: (02) 9964 8400 Fax: (02) 9964 8410

Date first listed: 24/08/2000
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Research, develop, and commercialise effective treatments for liver cancer using small particle technology

News & Events

Expand this box to read and print

delisted from the close of trading on Monday, 24 September 2018, pursuant to Listing rule 17.11.	24/09/2018
we understand Grand Pharma Sphere (Australia Bidco) Pty Ltd, an entity owned by CDH Genetech Limited and China Grand Pharmaceutical and Healthcare Holdings Limited acquired all of the shares in SRX for the cash consideration of A$33.60 per share	24/09/2018
The scheme of arrangement by which Grand Pharma Sphere, an entity owned by CDH Genetech and China Grand Pharmaceutical and Healthcare Holdings would acquire all shares of Sirtex was implemented today.	20/09/2018
The securities of Sirtex Medical Limited will be suspended from quotation at the close of trading today, Thursday, 13 September 2018, in accordance with Listing Rule 17.2, following lodgement of the Federal Court of Australia orders with the Australian Securities and Investments Commission approving the scheme of arrangement by which Grand Pharma Sphere (Australia Bidco) Pty Ltd, an entity owned by CDH Genetech Limited and China Grand Pharmaceutical and Healthcare Holdings Limited will acquire all of the issued shares in SRX.	13/09/2018
listed entity carried for record purposes only	01/07/2004

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
25/08/2017	Katherine Woodthorpe	2,000	$14.800	$29,600.00
23/08/2017	Neville Mitchell	6,000	$14.566	$87,397.00
26/10/2016	Gilman Wong	-74,968	$28.484	$2,135,378.00
28/09/2015	Richard Hill	3,000	$33.438	$100,314.00
19/07/2013	Gilman Wong	-30,106	$11.848	$356,684.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Nigel Lange	CEO	13/01/2017
Darren Smith	CFO, Company Secretary	26/02/2009
Neville Mitchell	Independent Director	10/04/2017
Katherine Woodthorpe	Independent Director	22/09/2015
Andrew McLean	Executive Director, CEO	05/06/2017

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.